Floatz logo

mln8054

Colon Neoplasm

Millennium Pharmaceuticals, Inc.Small moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

19 Active assets in the Colon Neoplasm cohort.

Asset / SponsorPhaseRating
Eloxatin
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2BB
Tranexamic Acid
Assaf-Harofeh Medical Center
Phase 4BB
FLUOROURACILUM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2BB
Regorafenib
City of Hope Medical Center
Phase 2B
Irinotecan
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2B

View all 34 →

Same molecule, other indications

mln8054 is also rated in:

urinary bladder neoplasmDormant
CC
Indicative ·
43 / 100
View asset →
breast neoplasmDormant
CC
Indicative ·
41 / 100
View asset →
pancreatic neoplasmDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →